Healthcare Global Enterprises working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

29.75×	29.75×	30.08×	31.08×	29.38×	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
58.91×	58.91×	57.06×	56.94×	56.00×
180.65×	180.65×	193.41×	203.26×	213.84×
−91.99×	−91.99×	−106.27×	−115.24×	−128.46×
30.63×	29.67×	−10.97×	−29.95×	168.94×
0.68×	0.68×	0.71×	0.76×	0.75×
15.24×	15.24×	6.49×	6.89×	14.28×
0.75×	0.75×	0.82×	0.86×	0.84×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HCG₹591.45

Healthcare Global Enterprises Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS RAINBOW JLHL CORONA MARKSANS METROPOLIS PARKHOSPSMcap ₹8,511 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Inventory Days (DIO)	29.38	31.08	30.08	29.75	29.75
Receivable Days (DSO)	56.00	56.94	57.06	58.91	58.91
Payable Days (DPO)	213.84	203.26	193.41	180.65	180.65
Cash Conversion Cycle (days)	-128.46	-115.24	-106.27	-91.99	-91.99
Working Capital Turnover	168.94	-29.95	-10.97	29.67	30.63
Asset Turnover	0.75	0.76	0.71	0.68	0.68
Cash Conversion (CFO/Net Income)	14.28	6.89	6.49	15.24	15.24
CFO/EBITDA	0.84	0.86	0.82	0.75	0.75

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.